Liver dialysis device proved safe and effective for treating severe liver failure

June 13, 2023
This study is one of the first-in-human randomized, controlled clinical trial of a liver dialysis device.

A successful in-patient trial of liver dialysis has been completed by researchers from UCL, the Royal Free Hospital, UCL spin-out Yaqrit and their collaborators. 

The DIALIVE device, invented by researchers at UCL’s Institute for Liver and Digestive Health, was found to be safe and was associated with substantial improvement in the severity of symptoms and organ function in a greater proportion of patients with acute-on-chronic liver failure (ACLF), when compared with patients receiving standard of care. 

The next step will be a larger clinical trial, which if successful could see DIALIVE approved for clinical use within the next three years. 

UCL release on Newswise

ID 337507613 © Dmitriy Tur | Dreamstime.com
dreamstime_xxl_337507613
ID 66537811 © Chirawan Somsanuk | Dreamstime.com
dreamstime_xxl_66537811
ID 122174126 © Artinun Prekmoung | Dreamstime.com
dreamstime_xxl_122174126
ID 344171255 © Yuri Arcurs | Dreamstime.com
dreamstime_xxl_344171255
ID 58652859 © Flydragonfly | Dreamstime.com
dreamstime_xxl_58652859